Carregant...
Perspectives on the clinical development of immunotherapy in prostate cancer
Despite impressive survival benefits with immunotherapy in patients with various solid tumors, the full potential of these agents in prostate cancer has yet to be realized. Sipuleucel-T demonstrated a survival benefit in this population, indicating that prostate cancer is an immunoresponsive disease...
Guardat en:
| Publicat a: | Asian J Androl |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952479/ https://ncbi.nlm.nih.gov/pubmed/29582792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_9_18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|